Flow Cytometry Antibodies for Non-Human Primate Research

Non-human primates (NHPs), particularly macaques such as cynomolgus and rhesus monkeys, are widely recognized as one of the most translationally relevant animal models in biomedical research and drug development. In many cases, therapeutic antibodies or immunomodulatory drugs exhibit species-specific target binding, meaning that rodent models cannot adequately reflect human pharmacology. Due to their close genetic, physiological, and immunological similarity to humans, NHP models play a critical role in evaluating therapeutic antibodies, biologics, and immune-modulating drugs before clinical trials.

Flow cytometry has become an essential analytical tool for studying immune responses in these models. By enabling high-dimensional analysis of immune cell populations and their activation states, flow cytometry allows researchers to evaluate changes in immune cell subsets, functional markers, and cytokine expression in response to drug candidates, vaccines, or disease processes. However, researchers often face a major challenge: the limited availability of antibodies specifically validated for monkey immune markers. Many laboratories rely on cross-reactive anti-human antibodies, which can lead to inconsistent performance, weak signals, or poor reproducibility.

To address these challenges, Creative diagnostics has developed a panel of high-quality antibodies specifically for monkey immune cell surface markers. These antibodies enable precise immune monitoring and support reliable non-human primate immunophenotyping and translational research.

Fig.1 Quantification of immune cells and cell-surface markers measured in the Milieu Intérieur cohort.

Key Features

• Broad Target Coverage for Comprehensive Immune Profiling
  Our antibody panel targets a wide range of monkey immune cell surface markers, supporting detailed characterization of major immune cell populations. This broad marker coverage enables researchers to build multiparameter flow cytometry panels for in-depth NHP immunophenotyping.
• High Specificity for Monkey Targets
  These antibodies are optimized for high specificity toward non-human primate antigens, enabling accurate detection of monkey immune markers with minimal background signal.
• Recombinant Antibody Technology
  All antibodies in this panel are generated using recombinant antibody technology, which offers significant advantages over traditional hybridoma-derived antibodies including: Higher binding specificity, Improved affinity for target antigens, Exceptional batch-to-batch consistency, Long-term reagent stability. Compared with conventional monoclonal antibodies, recombinant antibodies provide superior reproducibility and reliability for long-term preclinical research programs.
• Excellent Signal-to-Noise Ratio
  Our antibodies are optimized to deliver strong fluorescence signals with low background noise, making them ideal for high-sensitivity flow cytometry applications. Researchers may benefit from: Clear separation of positive and negative populations, Reliable detection of low-abundance markers, Improved experimental reproducibility.